Kidney-targeted irradiation triggers renal ischemic preconditioning in mice
- 1 August 2022
- journal article
- research article
- Published by American Physiological Society in American Journal of Physiology-Renal Physiology
- Vol. 323 (2) , F198-F211
Abstract
Renal ischemia-reperfusion (I/R) causes acute kidney injury (AKI). Ischemic preconditioning (IPC) attenuates I/R-associated AKI. Whole body irradiation induces renal IPC in mice. Still, the mechanisms remain largely unknown. Furthermore, the impact of kidney-centered irradiation on renal resistance against I/R has not been studied. Renal irradiation (8.5 Gy) was done in male 8- to 12-wk-old C57bl/6 mice using a small animal radiation therapy device. Left renal I/R was performed by clamping the renal pedicles for 30 min, with simultaneous right nephrectomy, at 7, 14, and 28 days postirradiation. The renal reperfusion lasted 48 h. Following I/R, blood urea nitrogen (BUN) and serum creatinine (SCr) levels were lower in preirradiated mice compared with controls; so was the histological Jablonski score of AKI. The metabolomics signature of renal I/R was attenuated in preirradiated mice. The numbers of proliferating cell nuclear antigen (PCNA)-, cluster of differentiation molecule 11b (CD11b)-, and cell surface glycoprotein F4/80-positive cells in the renal parenchyma post-I/R were reduced in preirradiated versus control groups. Such IPC was significantly observed as early as day 14 postirradiation. RNA sequencing showed an upregulation of angiogenesis- and stress response-related signaling pathways in irradiated nonischemic kidneys on day 28. Qualitative RT-PCR confirmed the increased expression of vascular endothelial growth factor (VEGF), activin receptor-like kinase 5 (ALK5), heme oxygenase-1 (HO1), platelet endothelial cell adhesion molecule-1 (PECAM1), NADPH oxidase 2 (NOX2), and heat shock proteins 70 and 27 (HSP70 and HSP27, respectively) in irradiated kidneys compared with controls. In addition, irradiated kidneys showed an increased CD31-positive vascular area compared with controls. A 14-day gavage of irradiated mice with the antiangiogenic drug sunitinib before I/R abrogated the irradiation-induced IPC at both functional and structural levels. Our observations suggest that kidney-centered irradiation activates proangiogenic pathways and induces IPC, with preserved renal function and attenuated inflammation post-I/R. NEW & NOTEWORTHY This study based on a mouse model of renal ischemia-reperfusion (I/R) aimed to 1) test whether and how irradiation strictly centered on the kidney protects against the I/R injury and 2) determine the shortest efficient delay of kidney irradiation to achieve such nephroprotection. Kidney irradiation increased the vascular surface in the renal parenchyma and conferred resistance against renal I/R damage, which highlights novel putative strategies in the field of ischemic acute kidney injury.Keywords
Funding Information
- Fonds De La Recherche Scientifique - FNRS
- Fonds Léon Fredericq
This publication has 39 references indexed in Scilit:
- Neovascularization After Irradiation: What is the Source of Newly Formed Vessels in Recurring Tumors?JNCI: Journal of the National Cancer Institute, 2012
- Ischemic Preconditioning in the Animal Kidney, a Systematic Review and Meta-AnalysisPLOS ONE, 2012
- Cellular pathophysiology of ischemic acute kidney injuryJournal of Clinical Investigation, 2011
- Small animal radiotherapy research platformsPhysics in Medicine & Biology, 2011
- Characterization of image quality and image‐guidance performance of a preclinical microirradiatorMedical Physics, 2011
- Mind Your Salts: When the Inactive Constituent Isn’tMolecular Pharmacology, 2010
- Increased superoxide formation induced by irradiation preconditioning triggers kidney resistance to ischemia-reperfusion injury in miceAmerican Journal of Physiology-Renal Physiology, 2009
- Multiple circulating proangiogenic factors induced by sunitinib malate are tumor-independent and correlate with antitumor efficacyProceedings of the National Academy of Sciences, 2007
- A preclinical review of sunitinib, a multitargeted receptor tyrosine kinase inhibitor with anti-angiogenic and antitumour activitiesAnnals of Oncology, 2007
- Incidence and Outcomes in Acute Kidney InjuryJournal of the American Society of Nephrology, 2007